Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lung Cancer Evaluation of TS-1 study.

Trial Profile

Lung Cancer Evaluation of TS-1 study.

Phase of Trial: Phase III

Latest Information Update: 03 Sep 2015

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Carboplatin; Paclitaxel
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms LETS
  • Most Recent Events

    • 07 Jul 2011 Final results presented at the 14th Annual Congress of the European Respiratory Society.
    • 07 Jun 2011 Status changed from active, no longer recruiting to completed, based on results reported in ASCO abstract.
    • 07 Jun 2011 Results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top